Trial Profile
Cannabidiol treatment of refractory epileptic spasms: an open label study
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 04 Feb 2021
Price :
$35
*
At a glance
- Drugs Cannabidiol (Primary)
- Indications Epilepsy; Infantile spasms
- Focus Adverse reactions; Expanded access; Therapeutic Use
- 05 Mar 2016 New trial record